Debt-to-equity in % of Structure Therapeutics Inc. from Q3 2023 to Q3 2025

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Structure Therapeutics Inc. quarterly Debt-to-equity history and change rate from Q3 2023 to Q3 2025.
Structure Therapeutics Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 5.8%, a 31% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

Structure Therapeutics Inc. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	5.8%	+1.4%	+31%	30 Sep 2025
Q2 2025	4.8%	-0.5%	-9.4%	30 Jun 2025
Q1 2025	4.1%	-3.3%	-45%	31 Mar 2025
Q4 2024	4.1%	-3%	-42%	31 Dec 2024
Q3 2024	4.4%	-7.4%	-63%	30 Sep 2024
Q2 2024	5.3%			30 Jun 2024
Q1 2024	7.4%			31 Mar 2024
Q4 2023	7.2%			31 Dec 2023
Q3 2023	12%			30 Sep 2023

* An asterisk sign (*) next to the value indicates that the value is likely invalid.